PubHawk
Arch Dermatol Res July 2024 PMID 39042295

Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study.

Eden David, Neda Shokrian, Ester Del Duca, Marguerite Meariman, Jacob Glickman, Sabrina Ghalili, Seungyeon Jung, Kathryn Tan, Benjamin Ungar, Emma Guttman-Yassky

Full text PDF Download social card

Mentions

2
Peak: 1 in Jul 2024
across 2 sources since Jul 2024

Extended reach

4,924
potential audience

Total likes

51

Video views

3,926

Mentions per month

Jul 2024 – Jan 2025

Where it's discussed

  • X / Twitter1 posts
  • YouTube1 videos

AI synopsis

What people are saying

We're still gathering social media discussions on this article. A synopsis appears once there are enough posts to summarize.

AgreementNeither agree nor disagree
InterestNeutral interest
EngagementNeutral engagement
ImpactNeutral impact

Abstract in brief

  • Alopecia areata (AA) is a type of hair loss linked to immune responses in atopic kids, with limited treatment options for them.
  • Dupilumab, a medication with a good safety profile, shows promise for helping hair regrowth in these pediatric AA patients.
  • A study involving 20 children revealed significant hair regrowth over an average follow-up of 67.6 weeks, highlighting the potential effectiveness of dupilumab, but further research is needed.
Read the full abstract

Top posts

Most liked on X and Bluesky
Mount Sinai Dermatology
@MSHSDerm · X

Jul 29, 2024 · 8 likes · 4 shares · 991 followers View post →

All mentions

Top 20 Hair Research Studies of 2024 Overview

Dr Donovan reviews the 20 most influential hair research studies published in 2024, focusing on novel treatments and safety evaluations. This yearly review highlights advancements in hair loss therapies, including…

Donovan Medical · Jan 3, 2025 2,937 views
Mount Sinai Dermatology
@MSHSDerm · X

Jul 29, 2024 · 8 likes · 4 shares · 991 followers View post →